Tag: SPYRAL HTN-ON MED

SPYRAL HTN-ON MED study demonstrates meaningful clinical benefits consistent with other SPYRAL HTN renal denervation trials

Coronary/Structural Heart by 0 comments

DUBLIN and CHICAGO, Nov. 7, 2022 /PRNewswire/ — Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced the six-month results from the full cohort of the SPYRAL HTN-ON MED clinical trial. The data were presented today as Late-Breaking Clinical Science at the […]

Continue Reading →